Comments by WIPO SCP Members and Observers on the WIPO Report on the International Patent System
On 3 February 2009 WIPO released the revised Report on the International Patent System (SCP/12/3 Rev.2) with three annexes. Continue Reading
Search Results for: ustr
Details emerge of secret ACTA negotiation
There are plans for the next ACTA negotiation to take place in Rabat, Morocco. However, since none of the Obama trade people have been placed at USTR, this might be delayed.
The USTR is still maintaining secrecy over details of the negotiation, including the names of participants and all of the proposed texts for negotiations. Despite this, KEI has obtained some documents related to the negotiations. We can report the following:
Deciphering consultant speak: Romulus, a case study
Romulus
Although the founding of Rome is a mystery, the myths of its origin hold that Romulus and Remus, the sons of Mars and Rhea Silvia, abandoned by their parents on the banks of the river Tiber, were suckled by a she-wolf, Lupa. Upon reaching adulthood, Romulus and Remus vied for control of Rome. According to Wikipedia,
Jan 16-17, 2009. KEI, HAI, MSF, Oxfam, UAEM & IQsensato Roundtable on prizes for Type II & III diseases, Geneva
Roundtable on De-linking R&D Incentives from Prices: Designing Innovation Inducement Prizes for Diagnostics, New Drugs and Vaccines for Type II and III diseases and conditions, with a particular focus on TB and Chagas Disease
The meeting is going to be small with around 40 high level policy makers and technical participants, including industry, donors, civil society and government officials.
WIPO patent committee resumes work on a positive agenda (March 2009)
The 13th session of the WIPO Standing Committee on the Law of Patents (SCP) will take place from March 23, 2009 to March 27, 2009 in Geneva at WIPO headquarters. The WIPO Report on the International Patent System is the first substantive agenda item of the 13th session. Continue Reading
Obama transition – Economics and Trade
Who is advising Obama during the transition? An army of well connected people. Here are the team leaders for economics and international trade. Many have past public service and current charity work. For those now working in the for-profit sector, we have emphasized only the business ties.
Economics and International Trade Team Leads
Corporate, Investment, Law Firm and Consultant
Unbranding Medicines — Harvard workshop on generics
Today I am at Harvard, attending a workshop titled: Unbranding Medicines: the politics, promise, and challenge of generic drugs. This is put on by the Harvard Interfaculty Initiative on Medicines and Society. The program in general is quite impressive, particularly as regards to the depth of experience and knowledge about the generic drug industry, including its early origins.
I was asked to speak about the use of prizes. The slides from my presentation are here:
DCOS Agreement on Procurement in Support of Interoperability and Open Standards emerges at 3rd IGF, Hyderabad
6 December 2008
At the close of the final day of the 3rd Internet Governance Forum in Hyderabad, India, the Dynamic Coalition on Open Standards (DCOS) released an agreement entitled the “Dynamic Coalition on Open Standards (DCOS) Agreement on Procurement in Support of Interoperability and Open Standards.”
Under the procurement agreement, governments, publicly funded and non-profit institutions agree to promote interoperability and accessibility through the use of open standards.
Compulsory licensing
This is from an exchange on IP-Health.
———–
Dear Aidan and Thomas.
There are several things I could mention about this revised position on compulsory licenses, but I will begin with these.
Blogging the Washington DC HIF presentation
Yesterday December 1 2008, professors Aidan Hollis and Thomas Pogge presented their Health Impact Fund (HIF) proposal at Georgetown University in Washington, DC.
The meeting convened and moderated by the President of Georgetown University, Jack deGioia, was attended by 50/60 people and was structured with two presentations by the co-authors and a panel discussion by :
Paul Antony, M.D., Chief Medical Officer and Executive Director, PhRMA
Lawrence Gostin, J.D., Associate Dean and Timothy and Linda O’Neill Professor of Global Health Law, Georgetown University Law Center
Continue Reading